Short- and Long-Term Effects of Whole-Body Photobiomodulation in Type II Diabetes Patients: A Protocol for a Controlled Clinical Trial
- Conditions
- Type II Diabetes Mellitus
- Registration Number
- NCT07047248
- Lead Sponsor
- University of Malaga
- Brief Summary
The development of an integral and global treatment to improve the quality of life in those withType II Diabetes Patients is challenging, thus a whole body Photobiomodulation (PBM) therapy program is proposed as an effective option.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- NOT_YET_RECRUITING
- Sex
- All
- Target Recruitment
- 44
- Adults aged 30 to 70 years.
- Diagnosed with Type 2 Diabetes Mellitus (T2DM) according to the American Diabetes Association (ADA) criteria.
- HbA1c levels between 6.5% and 10% at screening.
- Stable diabetes management regimen (medications and lifestyle) for at least three months prior to enrollment
- Presence of severe diabetic complications (e.g., end-stage renal disease, proliferative diabetic retinopathy).
- History of photosensitivity or medical conditions exacerbated by light exposure.
- Use of medications or supplements known to significantly alter glucose metabolism, other than current stable diabetes management.
- Pregnant or lactating women.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Glucose Metabolism: Evaluated through changes in fasting blood glucose levels and HbA1c. Follow-ups at 3 months and 6 months post-intervention • Glucose Metabolism: Evaluated through changes in fasting blood glucose levels and HbA1c.
- Secondary Outcome Measures
Name Time Method Sleep Quality: Assessed through the Pittsburgh Sleep Quality Index (PSQI). Follow-ups at 3 months and 6 months post-intervention The Pittsburgh Sleep Quality Index (PSQI) is a widely used self-report questionnaire that assesses sleep quality over a one-month time interval.
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (1)
Dr
🇪🇸Granada, Spain
Dr🇪🇸Granada, Spain